West Pharmaceutical Services Share Holder Equity 2010-2022 | WST

West Pharmaceutical Services share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
  • West Pharmaceutical Services share holder equity for the quarter ending June 30, 2022 was $2.424B, a 19.28% increase year-over-year.
  • West Pharmaceutical Services share holder equity for 2021 was $2.335B, a 25.93% increase from 2020.
  • West Pharmaceutical Services share holder equity for 2020 was $1.855B, a 17.88% increase from 2019.
  • West Pharmaceutical Services share holder equity for 2019 was $1.573B, a 12.67% increase from 2018.
West Pharmaceutical Services Annual Share Holder Equity
(Millions of US $)
2021 $2,335
2020 $1,855
2019 $1,573
2018 $1,396
2017 $1,280
2016 $1,118
2015 $1,024
2014 $957
2013 $906
2012 $729
2011 $655
2010 $626
2009 $579
West Pharmaceutical Services Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $2,424
2022-03-31 $2,326
2021-12-31 $2,335
2021-09-30 $2,202
2021-06-30 $2,033
2021-03-31 $1,829
2020-12-31 $1,855
2020-09-30 $1,719
2020-06-30 $1,606
2020-03-31 $1,490
2019-12-31 $1,573
2019-09-30 $1,488
2019-06-30 $1,445
2019-03-31 $1,370
2018-12-31 $1,396
2018-09-30 $1,352
2018-06-30 $1,282
2018-03-31 $1,305
2017-12-31 $1,280
2017-09-30 $1,317
2017-06-30 $1,242
2017-03-31 $1,169
2016-12-31 $1,118
2016-09-30 $1,142
2016-06-30 $1,109
2016-03-31 $1,074
2015-12-31 $1,024
2015-09-30 $995
2015-06-30 $989
2015-03-31 $941
2014-12-31 $957
2014-09-30 $970
2014-06-30 $973
2014-03-31 $935
2013-12-31 $906
2013-09-30 $837
2013-06-30 $784
2013-03-31 $746
2012-12-31 $729
2012-09-30 $717
2012-06-30 $680
2012-03-31 $695
2011-12-31 $655
2011-09-30 $691
2011-06-30 $696
2011-03-31 $663
2010-12-31 $626
2010-09-30 $632
2010-06-30 $571
2010-03-31 $580
2009-12-31 $579
2009-09-30 $566
2009-06-30 $533
2009-03-31 $489
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.398B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
McKesson (MCK) United States $50.991B 14.81
AmerisourceBergen (ABC) United States $30.314B 13.39
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
CONMED (CNMD) United States $2.967B 29.25
Invacare (IVC) United States $0.033B 0.00